Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology · Autoimmune Encephalitis

Can Prior Treatments Cause False-Negative Antibody Tests?

At a Glance

Steroids, IVIG, and plasma exchange can sometimes lower or interfere with autoimmune encephalitis antibody test results, especially in blood samples collected after treatment. A negative result does not rule out the disease; doctors also consider spinal fluid, symptoms, MRI, EEG, and other causes.

It is a common and stressful scenario: you or your loved one started treatment for suspected autoimmune encephalitis before the antibody test results came back, or testing was only done after treatments like steroids or plasma exchange had already begun. This leads to an important question: can these early treatments cause an antibody test to come back falsely negative?

The answer is that treatment can sometimes reduce the sensitivity of some tests, though a negative result after treatment is not automatically a false negative. Treatments that suppress or remove antibodies can reduce their levels, which may lead to a false-negative result, but the effect depends heavily on the specific treatment, the timing, and whether blood or spinal fluid was tested [1][2].

How Specific Treatments Affect Antibody Levels

Different treatments impact the immune system and antibody levels in different ways:

  • Plasma Exchange (PLEX) and Immunoadsorption: These treatments involve filtering the blood. Their primary goal is to physically remove harmful circulating antibodies from your bloodstream [3][1]. Because they are highly effective at this job, blood samples (serum) drawn after these treatments are at a higher risk of testing negative. However, plasma exchange primarily affects the circulating blood, so its effect on the spinal fluid (CSF) is not equivalent.
  • Intravenous Immunoglobulin (IVIG) and Corticosteroids: These treatments work to calm the immune system. Research shows that antibody levels can sometimes fall following these treatments, but the effects are highly variable and often not immediate [2][4]. Additionally, IVIG has complex effects—because it is made from donor antibodies, it can sometimes interfere with testing and even cause misleading positive results.

If you had testing done after these treatments, your neurologist and the testing laboratory will need to carefully review the exact treatment and collection dates to interpret the results accurately.

The Importance of Timing: Draw Before You Treat (If Safe)

Because immunotherapy can alter test results, medical guidelines strongly recommend that doctors collect both serum (the liquid part of the blood) and CSF (the fluid surrounding the brain and spinal cord) before starting any immune treatments, whenever it is safely possible [5].

However, suspected autoimmune encephalitis can require urgent hospital evaluation and treatment, and urgent care should never be dangerously delayed just to wait for an antibody test result or a lumbar puncture [6][7]. Under urgent specialist care, and after appropriate evaluation and treatment for potential infections (like the herpes simplex virus), many patients are appropriately started on initial (empiric) immune treatments before all testing is complete. You should not start, stop, or delay treatment based on an antibody result alone.

Other Reasons for False Negatives

Beyond prior treatment, several other factors can lead to a negative test result when autoimmune encephalitis is actually present:

  • Testing Only Blood or Only Spinal Fluid: Some autoantibodies are easily found in the blood, while others are heavily concentrated in the spinal fluid [5]. For instance, NMDA receptor antibodies are generally more sensitive in CSF, while LGI1 antibodies might show up better in serum [8]. Testing both is essential to avoid missing the diagnosis [9].
  • Disease Stage: Antibody levels naturally fluctuate depending on how long you have been sick [10].
  • Assay Limitations: The standard laboratory methods used to detect a target (commercial cell-based assays) in many hospitals can sometimes miss antibodies [11]. If clinical suspicion remains high despite a negative test, doctors can consult with a laboratory experienced in autoimmune neurology. They may suggest a tissue-based assay, which is a broader screening method, though it is not automatically more accurate and usually requires confirmation [12].

Seronegative Autoimmune Encephalitis

Ultimately, a negative antibody test does not definitively rule out autoimmune encephalitis, nor does it mean your symptoms are imagined. Doctors diagnose “seronegative” (antibody-negative) autoimmune encephalitis by carefully applying clinical criteria. This involves evaluating your symptoms, MRI scans, EEG (brain wave) results, and signs of inflammation in the spinal fluid [13].

It is important to note that MRI, EEG, and CSF tests can sometimes be normal, so their absence does not automatically rule out the disease either. A seronegative diagnosis also strictly requires excluding other causes, such as infections, seizures, toxic-metabolic disease, and malignancy [13].

Common questions in this guide

Can treatment make an autoimmune encephalitis antibody test negative?
Yes. Plasma exchange and immunoadsorption can remove circulating antibodies, and steroids or IVIG may change antibody levels, so testing after treatment can be less sensitive in some situations. A negative result is not automatically false and must be interpreted with the treatment timing and whether blood or spinal fluid was tested.
Should blood and spinal fluid be tested before immune treatment?
Whenever it is safe and practical, clinicians generally collect both a blood sample and a spinal fluid sample before starting immune treatment. However, suspected autoimmune encephalitis may require urgent evaluation and treatment, so care should not be dangerously delayed just to obtain testing.
Does plasma exchange affect blood antibody results more than spinal fluid results?
Plasma exchange primarily removes antibodies circulating in the blood, so a blood sample collected afterward may be more likely to test negative. Its effect on antibodies in spinal fluid is not equivalent, which is why the sample type and collection date matter.
Can someone have autoimmune encephalitis even when antibody tests are negative?
Yes. Some people have autoimmune encephalitis without a detectable antibody, a situation called seronegative autoimmune encephalitis. Doctors may use symptoms, MRI, EEG, spinal fluid findings, and exclusion of infections and other conditions to make the diagnosis.
Why are both blood and spinal fluid tested for autoimmune encephalitis?
Different antibodies are more readily detected in different samples. NMDA receptor antibodies are generally more sensitive in spinal fluid, while LGI1 antibodies may be detected more reliably in blood, so testing both can reduce missed diagnoses.
Can IVIG interfere with autoimmune encephalitis antibody testing?
Yes. IVIG contains antibodies from donors and can sometimes interfere with antibody testing, including causing a misleading positive result. Its effect can vary, so the neurologist and laboratory should review the treatment details and the exact dates of IVIG and sample collection.
Should urgent treatment wait until autoimmune encephalitis antibody results are back?
Urgent treatment should not be postponed solely while waiting for an antibody result or lumbar puncture. After appropriate evaluation for other urgent causes, including infections such as herpes simplex, doctors may begin immune treatment when it is clinically appropriate.

Get notified when new evidence is published on Non-specific autoimmune supratentorial encephalitis without characteristic antibodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Apheresis in Autoimmune Encephalitis and Autoimmune Dementia.

    Rössling R, Prüss H

    Journal of clinical medicine 2020; (9(9)) doi:10.3390/jcm9092683.

    PMID: 32824982
  2. 2

    Novel cerebrospinal fluid anti-central nervous system IgG antibodies can identify immunotherapy-responsive neuropsychiatric disorders.

    Preßler H, Bünger I, Prüss H

    Frontiers in immunology 2025; (16()):1612844 doi:10.3389/fimmu.2025.1612844.

    PMID: 40692787
  3. 3

    Lymphocytes in autoimmune encephalitis: Pathogenesis and therapeutic target.

    Chen J, Qin M, Xiang X, et al.

    Neurobiology of disease 2024; (200()):106632 doi:10.1016/j.nbd.2024.106632.

    PMID: 39117118
  4. 4

    Clinical heterogeneity and immunotherapy outcomes in anti-GAD65 antibody-associated autoimmune encephalitis: a retrospective study.

    Qiu Y, Huang Z, Ma T, et al.

    Therapeutic advances in neurological disorders 2026; (19()):17562864261456519 doi:10.1177/17562864261456519.

    PMID: 42293573
  5. 5

    Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis.

    Budhram A, Dubey D, Sechi E, et al.

    Clinical chemistry 2020; (66(12)):1496-1509 doi:10.1093/clinchem/hvaa254.

    PMID: 33221892
  6. 6

    Autoimmune Encephalitis.

    Jafarpour S, Santoro JD

    Pediatrics in review 2022; (43(4)):198-211 doi:10.1542/pir.2021-005096.

    PMID: 35362030
  7. 7

    Inpatient Management of Encephalopathy.

    Reddy P, Culpepper K

    Cureus 2022; (14(2)):e22102 doi:10.7759/cureus.22102.

    PMID: 35291547
  8. 8

    Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy.

    Bastiaansen AEM, de Bruijn MAAM, Schuller SL, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2022; (9(2)) doi:10.1212/NXI.0000000000001127.

    PMID: 34937737
  9. 9

    Antineuronal antibody titres in autoimmune encephalitis: clinical implications for diagnosis and long-term immunotherapy.

    Schwab H, Kegele J, Kowarik MC, et al.

    Frontiers in immunology 2026; (17()):1771609 doi:10.3389/fimmu.2026.1771609.

    PMID: 41884821
  10. 10

    Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.

    Grüter T, Möllers FE, Tietz A, et al.

    Brain : a journal of neurology 2023; (146(2)):600-611 doi:10.1093/brain/awac090.

    PMID: 35259208
  11. 11

    Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis.

    Ruiz-García R, Muñoz-Sánchez G, Naranjo L, et al.

    Frontiers in immunology 2021; (12()):691536 doi:10.3389/fimmu.2021.691536.

    PMID: 34267758
  12. 12

    Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease.

    Dalmau J, Graus F

    The Lancet. Neurology 2023; (22(6)):529-540 doi:10.1016/S1474-4422(23)00083-2.

    PMID: 37210100
  13. 13

    A clinical approach to diagnosis of autoimmune encephalitis.

    Graus F, Titulaer MJ, Balu R, et al.

    The Lancet. Neurology 2016; (15(4)):391-404.

    PMID: 26906964

This page is for informational purposes only and does not constitute medical advice. Your neurologist and testing laboratory should interpret antibody results in the context of treatment timing, sample type, and your overall evaluation.